Abstract
Results of the present study suggest that methylprednisolone, 30 mg/kg, administered in multiple doses beginning 7 hours after the initial plasma CPK elevation, is deleterious in patients with acute myocardial infarction and leads to an increased infarct size and an increased incidence and persistence of malignant ventricular dysrhythmia.